Embryogenesis of Transposition of the Great Arteries
2002; Lippincott Williams & Wilkins; Volume: 91; Issue: 2 Linguagem: Inglês
10.1161/01.res.0000028301.40791.4f
ISSN1524-4571
Autores Tópico(s)Coronary Artery Anomalies
ResumoHomeCirculation ResearchVol. 91, No. 2Embryogenesis of Transposition of the Great Arteries Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBEmbryogenesis of Transposition of the Great ArteriesA Lesson From the Heart Margaret L. Kirby Margaret L. KirbyMargaret L. Kirby From the Neonatal-Perinatal Research Institute, Division of Neonatology, Department of Pediatrics, Duke University Medical Center, Durham, NC. Originally published26 Jul 2002https://doi.org/10.1161/01.RES.0000028301.40791.4FCirculation Research. 2002;91:87–89Defective development of the cardiac outflow tract results in congenital cardiac anomalies that are known clinically as conotruncal defects. Development of the outflow tract is complicated, and the large number of conotruncal malformations that are seen in children reflects this complexity. Historically, knowledge of the embryogenesis of any heart defects has been difficult to attain because of the lack of models in which the pathogenesis of the defect could be studied prospectively. It is not difficult to induce cardiac malformations experimentally in animals but such malformations are not consistently of the same type, even using the same experimental paradigm. It is difficult to study a particular outflow malformation in a model with only 20% or even 50% incidence of the malformation. There is another problem with outflow development that further confounds our understanding: many but not all of the outflow malformations are related to each other in that they represent more or less severe manifestations of the same developmental pathology.1The retinoic acid model was one of the earliest teratogenic models of heart defects in the 1940s and 50s.2 A strain of keeshound dog developed by Patterson became the first genetic model to be studied extensively.3 Both of these models provided information about the morphology of some defects at various stages of development, but these models said little about the pathogenesis of the defects because of the problems mentioned above, ie, variability and low penetrance of any particular phenotype.The first and (possibly) most informative model of heart defects was the neural crest ablation model in chick embryos.4 This model produced an incidence of 90% persistent truncus arteriosus and has become the "gold standard" for this type of defect. Although this model led to a number of misunderstandings about the defects that can be directly attributed versus those that are secondary to neural crest malfunction, it has recently led to the finding that some outflow defects may be caused by failure of addition of the outflow myocardium from a newly identified secondary heart field5 (reviewed in Kelly and Buckingham6). The spectrum of defects associated with failure of the addition of outflow myocardium includes any defect with overriding aorta, ie, tetralogy of Fallot and double outlet right ventricle. It seems pretty clear now that neural crest regulates growth factor availability in the pharynx, which in turn affects addition of myocardium from the secondary heart field to the outflow tract. Thus, it is now believed that absence of neural crest is directly associated with absence of the outflow septum in persistent truncus arteriosus, but only indirectly with malalignment defects that have overriding aorta, because the primary cause of the defects in this case is the failure of the addition of myocardium from the secondary heart field.7However, neural crest ablation and the process of addition of myocardium to lengthen the outflow tract for proper alignment does not address a major type of outflow tract defect found clinically called transposition of the great arteries. This malformation, which is the most common cyanotic heart defect identified in the first week of life, occurs in approximately 4 in 10 000 infants.7a In transposition of the great arteries, both the aorta and pulmonary trunk are connected to the wrong ventricle. Pediatric cardiologists and pathologists refer to this as ventriculoarterial discordance: the aorta arises from the right ventricle, whereas the pulmonary trunk arises from the left ventricle. In other words, newly oxygenated blood from the lungs returns to the heart only to be sent back to the lungs rather than being delivered to the oxygen starved body. Conversely, oxygen-poor blood returns to the heart from the body and is immediately sent back to the body without being reoxygenated. In babies with this defect who survive birth there is an obligatory associated heart defect that permits the mixing of the systemic and pulmonary circulations to provide some oxygenated blood to the body. Without such a defect, the condition is quickly fatal.The pathogenesis of transposition of the great arteries was traditionally lumped with other malalignment defects of the outflow tract like double outlet right ventricle and tetralogy of Fallot, many of which were seen after neural crest ablation. It was something of a surprise that transposition wasn't seen in the neural crest ablation spectrum, and so most recent thought about the pathogenesis of the defect has considered it outside of any known mechanism.The study by Costell et al8 in this issue of Circulation Research presents the most promising, if not the first, animal model of transposition of the great arteries. They show that the perlecan-null mouse has what is clinically known as "common" or "isolated" SDD transposition of the great arteries (formerly called D-transposition). For anyone who does not thrive on the minute details of heart morphology, the mention of transposition of the great arteries brings apprehension because of the complexity of classifications of the defects. There are 3 points of reference for transposition: the position of the arterial trunks, the emergence of the arterial trunks from the ventricular chambers, and the relationship of the ventricles to the atrioventricular valves. In common transposition, the form reported by Costell et al,8 the discordance is between the ventricles and the arteries (ventriculoarterial) with no discordance between the atria and the ventricles; in other words, it is "isolated" ventriculoarterial discordance.Transposition can also occur as congenital, physiologically corrected transposition (designated SLL or IDD transposition). This happens when the heart loops to the wrong side or the atria are reversed. These physiological corrections are mostly associated with abnormal situs, or placement of the asymmetric organs. Several animal models of transposition with altered situs are existent. One is teratogenic, our old friend retinoic acid, and several others are genetically induced. The genetic models harbor null mutations in several different genes: type IIB activin receptor10 and cryptic11 show the clearest examples of transposition, although this phenotype is only one of several outflow defects, ie, double outlet right ventricle and persistent truncus arteriosus, seen in these mutants. Retinoic acid shows a dose-dependent differential induction of transposition of the great arteries at high doses and dextroposition of the aorta at low dose.9 Because retinoic acid and the knockouts of the genes associated with retinoid signaling cause such complex phenotypes, it is difficult to assess pathogenesis of transposition in these models. More promising are the gene knockouts of Activin IIB receptor10 and cryptic.11 However, all of these perturbations alter left-right axis determination and ventricular septation, which are defects associated with physiologically corrected transposition. Importantly, in these models transposition occurs only infrequently in the spectrum of other outflow malformations.In contrast to the other models of transposition, which are physiologically corrected, that of Costell et al8 presents common or uncorrected transposition. The high incidence of common transposition (11 of 15 perlecan-null embryos) with intact ventricular septum (10 of 11) is not found in any other animal models. Intact septum is found with some frequency in humans with transposition.So, what is perlecan and how does it cause transposition of the great arteries? Perlecan is a heparan sulfate proteoglycan (HSPG2) that is expressed in all basement membranes, in cartilage, and several other mesenchymal tissues during development including, according to new data presented by Costell et al,8 the cardiac neural crest. Perlecan binds growth factors and interacts with various extracellular matrix proteins and cell adhesion molecules. Because the heparan sulfate side chains bind fibroblast growth factors (FGFs), perlecan may even serve as a low-affinity receptor. If so, perlecan could modulate a number of other FGF-controlled processes.12,13The other aspects of the phenotype in perlecan-null mice are associated with deterioration of well-formed basement membranes, suggesting that perlecan is needed for stabilization of basement membranes.14 There are two existent functional knockouts of perlecan, which involve deletion of one exon: exon 6 in the mouse reported by Costell et al8 in this issue, and exon 7 from a separate group.15 In both, either the transcript or the protein is missing, so both appear to be functionally null mutations. The phenotype of the mouse with exon 7 deletion is similar to the one with the exon 6 deletion but transposition has not been analyzed in the exon 7 deleted line.Most of the perlecan-null embryos die by embryonic day 13.5. All of these embryos are normal in size and generally well-formed. The embryos die because the compact myocardium leaks blood into the pericardial space because it lacks stable basement membranes. A second smaller population of embryos survives the second half of gestation, but these develop osteochondrodysplasia characterized by disrupted collagen synthesis and assembly because perlecan protects cartilage extracellular matrix from degradation.14 This type of chondrodysplasia is seen in a human disease called Silverman-Handmaker type dyssegmental dysplasia, which is a lethal autosomal recessive form of dwarfism. The phenotype of the perlecan-null mouse led to the linkage of perlecan gene mutations in patients with Silverman-Handmaker dwarfism.16 Thus, the perlecan mouse has already served us well in the quest to find genetic linkages with human diseases. A cardiovascular phenotype has never been reported in patients with Silverman-Handmaker syndrome, some of whom are effectively null for perlecan. Although there is no empirical explanation for this discrepancy between the mouse and human phenotypes, it is possibly the result of functional redundancy in the human genome.Although myocardial problems were identified in the original articles describing the phenotype of the perlecan-null mouse, cardiac malformations were not noted. The present finding of common transposition in perlecan-null mice represents a second look at the heart morphology of these embryos. Perlecan-null embryos showed no abnormalities in the morphology or placement of the lungs, liver, stomach, and spleen, which are sentinel organs for assessing normal left-right axis determination. The significance of this should now be obvious as the perlecan-null mouse represents the first animal model of common or isolated transposition.Costell et al8 describe alterations in the mesenchyme of the outflow tract that disrupted the formation of the outflow tract cushions. These cushions are ridges that serve as a template for septation of the outflow tract. In normal development they spiral in a counterclockwise manner when viewed from above. The mesenchyme of the outflow tract has two well-described origins: endocardial cell-derived mesenchyme that arises by epithelial-to-mesenchymal transformation,17 and cells migrating from the pharyngeal arches.18 The cells that migrate from the pharyngeal arches are mostly derived from neural crest but may also be from other sources.19 Disruption of the ridge pattern in the lumen of the outflow tract results in formation of a straight outlet septum rather than a spiraling septum. The spiraling septum ensures connection of the left ventricle with the systemic circulation via the aorta and the right ventricle with the pulmonary circulation via the pulmonary trunk.One limitation of the study by Costell et al8 is the lack of definitive demonstration that the overpopulating mesenchymal cells of the outflow tract are derived from neural crest and that these cells express perlecan. A major problem in studying cardiac neural crest cells in the mouse has been our lack of markers to specifically identify them. This problem was solved in the last few years with the availability of several genetically altered mouse lines with marked neural crest cells.20–22 In the absence of data from crossbreeding, one of these lines of mice with marked neural crest with the perlecan-null mutant, the authors have done the best analysis that is possible, ie, using α-smooth muscle actin as a marker for neural crest cells.23Resolution of the neural crest issue using appropriate lineage tracing techniques in the perlecan-null mutant mouse should yield a wealth of new information about the pathogenesis of common transposition. Regardless of the outcome, this mouse has my admiration as it has already provided more than its share of insight into human disease.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.My thanks to Steve Sanders for a lesson in transposition nomenclature and Karen Waldo, Mesud Yelbuz, Mary Hutson, Radwan Abu-Issa, Erik Meyers, and Tony Creazzo for critical reading of the manuscript and helpful discussions.FootnotesCorrespondence to Margaret L. Kirby, PhD, Box 3179, Neonatology, 307B Nanaline Duke Bldg, Research Drive, Dept of Pediatrics, DUMC, Durham, NC 20012. E-mail [email protected] References 1 Deleted in proof.Google Scholar2 Wilson JG, Warkany J. Cardiac and aortic arch anomalies in offspring of vitamin A deficient rats correlated with similar human anomalies. Pediatrics. 1950; 5: 708–725.CrossrefMedlineGoogle Scholar3 Patterson DF, Pyle RL, Van Mierop LHS, Melbin J, Olson M. Hereditary defects of the conotruncal septum in keeshond dogs: pathologic and genetic studies. Am J Cardiol. 1974; 34: 187–205.CrossrefMedlineGoogle Scholar4 Kirby ML, Gale TF, Stewart DE. Neural crest cells contribute to normal aorticopulmonary septation. Science. 1983; 220: 1059–1061.CrossrefMedlineGoogle Scholar5 Yelbuz TM, Waldo KL, Kumiski DH, Stadt HA, Wolfe RR, Leatherbury L, Kirby ML. Shortened outflow tract leads to altered cardiac looping after neural crest ablation. Circulation. 2002; 106: 504–510.LinkGoogle Scholar6 Kelly RG, Buckingham ME. The anterior heart-forming field: voyage to the arterial pole of the heart. Trends Genet. 2002; 18: 210–216.CrossrefMedlineGoogle Scholar7 Farrell MJ, Waldo KL, Li Y-X, Kirby ML. A novel role for cardiac neural crest in heart development. Trends Cardiovasc Med. 2000; 9: 215–220.Google Scholar7A Fanaroff J. Transposition of the great vessels. MEDLINEplus Medical Encyclopedia. Bethesda, Md: National Library of Medicine. Updated August 18, 2001.Google Scholar8 Costell M, Carmona R, Gustafsson E, Gonzáles-Iriarte M, Fässler R, Muñoz-Chápuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res. 2002; 91: 158–164.LinkGoogle Scholar9 Yasui H, Morishima M, Nakazawa M, Ando M, Aikawa E. Developmental spectrum of cardiac outflow tract anomalies encompassing transposition of the great arteries and dextroposition of the aorta: pathogenic effect of extrinsic retinoic acid in the mouse embryo. Anat Rec. 1999; 254: 253–260.CrossrefMedlineGoogle Scholar10 Oh SP, Li E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 1997; 11: 1812–1826.CrossrefMedlineGoogle Scholar11 Gaio U, Schweickert A, Fischer A, Garratt AN, Muller T, Ozcelik C, Lankes W, Strehle M, Britsch S, Blum M, Birchmeier C. A role of the cryptic gene in the correct establishment of the left-right axis. Curr Biol. 1999; 9: 1339–1342.CrossrefMedlineGoogle Scholar12 Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, a basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell. 1994; 79: 1005–1013.CrossrefMedlineGoogle Scholar13 Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest. 1998; 102: 1599–1608.CrossrefMedlineGoogle Scholar14 Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol. 1999; 147: 1109–1122.CrossrefMedlineGoogle Scholar15 Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet. 1999; 23: 354–358.CrossrefMedlineGoogle Scholar16 Arikawa-Hirasawa E, Wilcox WR, Yamada Y. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nature Genet. 2002; 27: 431–434.Google Scholar17 Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res. 1995; 77: 1–6.LinkGoogle Scholar18 Thompson RP, Fitzharris TP. Morphogenesis of the truncus arteriosus of the chick embryo heart: the formation and migration of mesenchymal tissue. Am J Anat. 1979; 154: 545–556.CrossrefMedlineGoogle Scholar19 Waldo KL, Lo CW, Kirby ML. Connexin 43 expression reflects neural crest patterns during cardiovascular development. Dev Biol. 1999; 208: 307–323.CrossrefMedlineGoogle Scholar20 Lo CW, Cohen MF, Huang GY, Lazatin BO, Patel N, Sullivan R, Pauken C, Park SM. Cx43 gap junction gene expression and gap junctional communication in mouse neural crest cells. Dev Genet. 1997; 20: 119–132.CrossrefMedlineGoogle Scholar21 Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cardiac neural crest. Development. 2000; 127: 1607–1616.CrossrefMedlineGoogle Scholar22 Yamauchi Y, Abe K, Mantani A, Hitoshi Y, Suzuki M, Osuzu F, Kuratani S, Yamamura K. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev Biol. 1999; 212: 191–203.CrossrefMedlineGoogle Scholar23 Ya J, Schilham MW, de Boer PA, Moorman AF, Clevers H, Lamers WH. Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ Res. 1998; 83: 986–994.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Buijtendijk M, Barnett P and Hoff M (2020) Development of the human heart, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 10.1002/ajmg.c.31778, 184:1, (7-22), Online publication date: 1-Mar-2020. Kugathasan K, Halford M, Farlie P, Bates D, Smith D, Zhang Y, Roy J, Macheda M, Zhang D, Wilkinson J, Kirby M, Newgreen D and Stacker S (2018) Deficiency of the Wnt receptor Ryk causes multiple cardiac and outflow tract defects, Growth Factors, 10.1080/08977194.2018.1491848, 36:1-2, (58-68), Online publication date: 4-Mar-2018. Mertens L, Vogt M, Marek J and Cohen M (2016) Transposition of the Great Arteries Echocardiography in Pediatric and Congenital Heart Disease, 10.1002/9781118742440.ch24, (446-465) Narematsu M, Kamimura T, Yamagishi T, Fukui M and Nakajima Y (2015) Impaired Development of Left Anterior Heart Field by Ectopic Retinoic Acid Causes Transposition of the Great Arteries, Journal of the American Heart Association, 4:5, Online publication date: 1-May-2015. Gouda Z, Elewa Y and Selim A (2015) Histological architecture of cardiac myofibers composing the left ventricle of murine heart, Journal of Histology and Histopathology, 10.7243/2055-091X-2-2, 2:1, (2) Capuani A (2014) The trabecula septomarginalis (Leonardo's cord) in abnormal ventriculo-arterial connections: anatomic and morphogenetic implications, Journal of Cardiothoracic Surgery, 10.1186/1749-8090-9-71, 9:1, Online publication date: 1-Dec-2014. Madonna R and De Caterina R (2014) Reprint of "Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis", Vascular Pharmacology, 10.1016/j.vph.2014.05.002, 62:3, (120-122), Online publication date: 1-Sep-2014. Madonna R and De Caterina R (2014) Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis, Vascular Pharmacology, 10.1016/j.vph.2013.12.002, 60:2, (49-51), Online publication date: 1-Feb-2014. Smith S (2010) Environmentally Induced Heart Malformations Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00720-X, (429-446), . Bajolle F, Zaffran S, Losay J, Ou P, Buckingham M and Bonnet D (2009) Conotruncal defects associated with anomalous pulmonary venous connections, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2008.04.010, 102:2, (105-110), Online publication date: 1-Feb-2009. Corno A and Kocica M (2007) Potential Implications of the Helical Heart in Congenital Heart Defects, Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual, 10.1053/j.pcsu.2007.01.001, 10:1, (61-67), Online publication date: 1-Jan-2007. Cipollone D, Amati F, Carsetti R, Placidi S, Biancolella M, D'Amati G, Novelli G, Siracusa G and Marino B (2006) A multiple retinoic acid antagonist induces conotruncal anomalies, including transposition of the great arteries, in mice, Cardiovascular Pathology, 10.1016/j.carpath.2006.04.004, 15:4, (194-202), Online publication date: 1-Jul-2006. Kinsella M and Wight T (2005) Perlecan: An Extracellular Matrix Heparan Sulfate Proteoglycan that Regulates Key Events in Vascular Development and Disease Chemistry and Biology of Heparin and Heparan Sulfate, 10.1016/B978-008044859-6/50023-X, (607-635), . Gruber P and Epstein J (2004) Development Gone Awry, Circulation Research, 94:3, (273-283), Online publication date: 20-Feb-2004. Webb S, Qayyum S, Anderson R, Lamers W and K. Richardson M (2003) Septation and separation within the outflow tract of the developing heart, Journal of Anatomy, 10.1046/j.1469-7580.2003.00168.x, 202:4, (327-342), Online publication date: 1-Apr-2003. Barnett J and Desgrosellier J (2003) Early events in valvulogenesis: A signaling perspective, Birth Defects Research Part C: Embryo Today: Reviews, 10.1002/bdrc.10006, 69:1, (58-72), Online publication date: 1-Feb-2003. July 26, 2002Vol 91, Issue 2 Advertisement Article InformationMetrics https://doi.org/10.1161/01.RES.0000028301.40791.4FPMID: 12142339 Originally publishedJuly 26, 2002 Keywordsperlecanhearttransposition of the great arteriesoutflow tractPDF download Advertisement
Referência(s)